Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment

MLA

Itamar Raz, et al. “Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment.” Diabetes Care, vol. 35, Feb. 2012, pp. 485–87. EBSCOhost, https://doi.org/10.2337/dc11-1942.

APA

Itamar Raz, Laurence Durrwell, John Hoekstra, Mark Boldrin, Raffaella Balena, Mark Kipnes, & Vivian Fonseca. (2012). Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment. Diabetes Care, 35, 485–487. https://doi.org/10.2337/dc11-1942

Chicago

Itamar Raz, Laurence Durrwell, John Hoekstra, Mark Boldrin, Raffaella Balena, Mark Kipnes, and Vivian Fonseca. 2012. “Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment.” Diabetes Care 35 (February): 485–87. doi:10.2337/dc11-1942.